← Leaderboards
Godela M Fick-Brosnahan
University Of Colorado Denver
$427,625
Attributed
$427,625
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $233.3K · FY2016–17$250K$187.5K$125K$62.5K$0
'16
'17
Funding mix
By agency
NIH$427,625 · 2
By mechanism
R21$427,625 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Robert W Schrier$16,805,433
- Shelley Deanne Miyamoto$5,520,361
- Berenice Yolande Gitomer$3,600,926
- Rytis Prekeris$11,820,680
- Yunxia Tao$650,800
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsAce InhibitorsAutosomal Dominant Polycystic KidneyAdenylate KinaseAdolescence (12-20)Adverse EffectsAffectAmlodipine-Amp-Activated Protein KinaseAnimal ModelAnti-InflammatoryAnti-Inflammatory AgentsAntioxidantsAtrophicAcute Renal Failure With Renal Papillary NecrosisAutosomal Dominant TraitBasic ScienceBiological PreservationBlood PressureBlood VesselsCell ProliferationCellular Metabolic ProcessCessation Of Life5&Apos
Grant awards (4)
Feasibility study of metformin therapy in ADPKD$194,375
R21 · FY2017 · DK · contact PI
Feasibility study of metformin therapy in ADPKD$233,250
R21 · FY2016 · DK · contact PI
Antihypertensive Therapy in Children with ADPKD$0
P01 · FY2002 · DK
Antihypertensive Therapy in Children with ADPKD$0
P01 · FY2001 · DK